Takeda Pharmaceutical Company Limited Unused Provision Reversed Other Provisions
Takeda Pharmaceutical Company Limited (TAK) reported Unused Provision Reversed Other Provisions of JPY 52.27 billion for the 12-month period ending 2025-03-31, per its 20-F filed 2025-06-25.
Financial Statements › Notes
ifrs-full:UnusedProvisionReversedOtherProvisions · last filed 2025-06-25
| Period end | Unused Provision Reversed Other Provisions 12 month |
|---|---|
| 2025-03-31 | 52.27B JPY 20-F · filed 2025-06-25 |
| 2024-03-31 | 44.57B JPY 20-F · filed 2025-06-25 |
| 2023-03-31 | 37.98B JPY 20-F · filed 2024-06-26 |
| 2022-03-31 | 30.51B JPY 20-F · filed 2023-06-28 |
| 2021-03-31 | 41.29B JPY 20-F · filed 2022-06-29 |